News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
Biotricity Inc. expects over 40% YoY decrease in Loss from Operations and over 10% YoY Margin Improvement. Anticipates meeting analyst revenue target with revenue growth over 24% YoY -
-
-
COMMUNIQUÉ DE PRESSE
Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares into Restricted Common Stock
Biotricity Inc. reports majority of Preferred A shareholders converted shares to Restricted Common Stock, showing strong support. Company achieves key milestones and approaches EBITDA neutrality -
-
-
COMMUNIQUÉ DE PRESSE
Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
Biotricity Inc. announces HeartSecure, a direct-to-consumer cardiac screening service for Americans at risk for heart disease, offering home-based solutions to improve healthcare accessibility
